Ana Alcafe
anaalcafe.bsky.social
Ana Alcafe
@anaalcafe.bsky.social
Ana Alonso-Carriazo Fernandez.
Postdoctoral Researcher in Carr's lab at UCL Institute of Ophthalmology.
Interested in CRISPR editing and eye disease modelling.
Reposted by Ana Alcafe
If you are attending the Turing AI UK 2025 conference today and tomorrow, come by the 1st floor to check out our stand. @x1xuan.bsky.social and I will be presenting our Multimodal Analytical Platform for the Delivery of Integrated Diagnostics in Oncology.

#AIUK @icr.ac.uk @maggiecheang.bsky.social
March 17, 2025 at 8:58 AM
Reposted by Ana Alcafe
This #RareDiseaseDay, we hosted a #Research Roadshow with @moorfieldsfriends.bsky.social, bringing groundbreaking science directly to patients and visitors. A huge thank you to all the labs that showcased their incredible work.

Read more: buff.ly/eF0yaKW

@ucleye.bsky.social #NIHRsupported
March 17, 2025 at 1:13 PM
Happy to see my review on Late-Onset Retinal Degeneration published! You can learn more about its features and C1QTNF5 function here: link.springer.com/chapter/10.1...
Late-Onset Retinal Degeneration: Clinical Features and C1QTNF5/CTRP5 Function
Late-onset retinal degeneration (L-ORD) is a rare autosomal dominant inherited macular disease caused by mutations in C1QTNF5 (CTRP5). While pathophysiological features vary, patients often present ye...
link.springer.com
February 14, 2025 at 11:51 AM
Reposted by Ana Alcafe
“The impact of the collective executive orders and directives appears devastating.” scim.ag/40ureTO
Trump hits NIH with ‘devastating’ freezes on meetings, travel, communications, and hiring
Researchers facing
scim.ag
January 22, 2025 at 11:28 PM
A bit about me: I moved to Ldn over 7 years ago, to do my MSc thesis and work as an RA investigating CAFs-tumour crosstalk in lung cancer at Barts Cancer Institute. In 2018, I pivoted to eye research and started my PhD at UCL Institute of Ophthalmology (1/5)
January 23, 2025 at 8:27 PM
First post here! I've never shared much on Twitter, even less when it became X... Will try to do better here, please be patient with me! 👋
January 23, 2025 at 4:45 PM